Chemoinformaics analysis of Eschscholtzxanthin
| Molecular Weight | 566.87 | nRot | 9 |
| Heavy Atom Molecular Weight | 512.438 | nRig | 25 |
| Exact Molecular Weight | 566.412 | nRing | 2 |
| Solubility: LogS | -6.311 | nHRing | 0 |
| Solubility: LogP | 4.309 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 96 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 40 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 104.411 |
| nHD | 2 | BPOL | 54.1732 |
| QED | 0.674 |
| Synth | 2.787 |
| Natural Product Likeliness | 1.302 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 1 |
| HIA | 0.003 |
| CACO-2 | -5.202 |
| MDCK | 0.0000346 |
| BBB | 0.914 |
| PPB | 0.931033 |
| VDSS | 1.217 |
| FU | 0.023355 |
| CYP1A2-inh | 0.854 |
| CYP1A2-sub | 0.9 |
| CYP2c19-inh | 0.062 |
| CYP2c19-sub | 0.851 |
| CYP2c9-inh | 0.014 |
| CYP2c9-sub | 0.833 |
| CYP2d6-inh | 0.956 |
| CYP2d6-sub | 0.934 |
| CYP3a4-inh | 0.465 |
| CYP3a4-sub | 0.496 |
| CL | 12.703 |
| T12 | 0.219 |
| hERG | 0.275 |
| Ames | 0.406 |
| ROA | 0.063 |
| SkinSen | 0.869 |
| Carcinogencity | 0.906 |
| EI | 0.026 |
| Respiratory | 0.84 |
| NR-Aromatase | 0.744 |
| Antiviral | Yes |
| Prediction | 0.649523 |